Vaccination contre l’hépatite B

[1]  S. Suissa,et al.  Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. , 2007, Archives of pediatrics & adolescent medicine.

[2]  S. Suissa,et al.  Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. , 2006, Brain : a journal of neurology.

[3]  A. Zanetti,et al.  Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study , 2005, The Lancet.

[4]  Ding‐Shinn Chen,et al.  Hepatitis B vaccination: to boost or not to boost? , 2005, The Lancet.

[5]  D. David,et al.  Surveillance épidémiologique des donneurs de sang homologues et risque résiduel en France entre 2001 et 2003 , 2005 .

[6]  M. Hernán,et al.  Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study [2] (multiple letters) , 2005 .

[7]  R. Jacobson,et al.  Prevention of Hepatitis B with the Hepatitis B Vaccine , 2004 .

[8]  M. Hernán,et al.  Recombinant hepatitis B vaccine and the risk of multiple sclerosis , 2004, Neurology.

[9]  F. Denis,et al.  Évolution des stratégies vaccinales et couverture vaccinale contre l’hépatite B en France, pays de faible endémie , 2004 .

[10]  P. van Damme,et al.  Hepatitis B vaccination for sex workers: do outreach programmes perform better? , 2003, Sexually transmitted infections.

[11]  J. Desenclos,et al.  Central demyelinating disorders and hepatitis B vaccination: a risk-benefit approach for pre-adolescent vaccination in France. , 2002, Vaccine.

[12]  H. Hsu,et al.  Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B Vaccination , 2001, Annals of Internal Medicine.

[13]  H. Hsu,et al.  Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. , 2001, The Journal of pediatrics.

[14]  F. Authier,et al.  Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. , 2001, Brain : a journal of neurology.

[15]  A. Sadovnick,et al.  School-based hepatitis B vaccination programme and adolescent multiple sclerosis , 2000, The Lancet.

[16]  F. Zipp,et al.  No increase in demyelinating diseases after hepatitis B vaccination , 1999, Nature Medicine.

[17]  S. Zamvil,et al.  Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis. , 1999, Current opinion in neurology.

[18]  B S Blumberg,et al.  Hepatitis B virus, the vaccine, and the control of primary cancer of the liver. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Flahault,et al.  Six ans de surveillance des hépatites A et B en médecine générale, en France , 1997 .

[20]  A. Flahault,et al.  Six years surveillance of hepatitis A and B in general practice in France. , 1997, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  M. Lai,et al.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.

[22]  J. Nadler.  Multiple sclerosis and hepatitis B vaccination. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Keyser,et al.  Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine , 1991, The Lancet.

[24]  H. Margolis,et al.  Hepatitis B: Evolving Epidemiology and Implications for Control , 1991, Seminars in liver disease.

[25]  E. Jury.  EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). , 2003 .

[26]  B. Koblin,et al.  Hepatitis B virus infection. , 1998, The New England journal of medicine.

[27]  M. Pelliccia,et al.  Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine. , 1997, Research in virology.

[28]  A. Goudeau,et al.  Incidence and prevalence of hepatitis B in France. , 1995, Vaccine.

[29]  F. Mahoney,et al.  Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection. , 1993, The Journal of infectious diseases.